CITIGROUP INC - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,491,379
+149.6%
83,772
+51.3%
0.00%
+100.0%
Q2 2023$998,020
-40.1%
55,384
-46.7%
0.00%0.0%
Q1 2023$1,667,301
+86.4%
103,817
+112.4%
0.00%0.0%
Q4 2022$894,339
-35.4%
48,871
-30.7%
0.00%0.0%
Q3 2022$1,384,000
+48.5%
70,486
+41.0%
0.00%0.0%
Q2 2022$932,000
+174.1%
49,980
+223.1%
0.00%
Q1 2022$340,000
-77.1%
15,470
-70.4%
0.00%
-100.0%
Q4 2021$1,484,000
+196.8%
52,223
+119.8%
0.00%
Q3 2021$500,000
+474.7%
23,763
+412.0%
0.00%
Q2 2021$87,000
+102.3%
4,641
+65.4%
0.00%
Q1 2021$43,000
-70.3%
2,806
-72.7%
0.00%
Q4 2020$145,000
+85.9%
10,261
+104.9%
0.00%
Q3 2020$78,000
-32.2%
5,007
-23.8%
0.00%
Q2 2020$115,000
+144.7%
6,570
+104.2%
0.00%
Q1 2020$47,000
-16.1%
3,217
+42.9%
0.00%
Q4 2019$56,000
+211.1%
2,251
+90.1%
0.00%
Q3 2019$18,000
-80.4%
1,184
-67.5%
0.00%
Q2 2019$92,000
+50.8%
3,643
+34.4%
0.00%
Q1 2019$61,000
+35.6%
2,710
+80.5%
0.00%
Q4 2018$45,000
-19.6%
1,501
-22.9%
0.00%
Q3 2018$56,0001,9460.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders